Table 3.
Association between SNPs and AML susceptibility.
| Gene | SNP | Model | Genotype | Control (n) | AML case (n) | χ2 test p value |
OR (95% CI) | Adjusted p value |
|---|---|---|---|---|---|---|---|---|
| CD163 | rs4883263 | Co-dominant | CC | 139 | 160 | 0.025 | ||
| CT | 148 | 111 | 0.644 (0.454-0.914) | 0.014 | ||||
| TT | 29 | 36 | 1.084 (0.619-1.899) | 0.778 | ||||
| Dominant | CC | 139 | 160 | 0.042 | ||||
| CT+TT | 177 | 147 | 1.397 (1.006-1.94) | 0.046 |
SNP, single nucleotide polymorphisms; AML, acute myeloid leukemia; OR, odds ratio; CI, confidence interval.
The bold values means statistically significant p-values.